We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
+8.81%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$122M
AUM Growth
-$81.7M
(-40%)
Cap. Flow
-$42.7M
Cap. Flow
% of AUM
-34.99%
Top 10 Holdings %
Top 10 Hldgs %
46.72%
Holding
148
New
36
Increased
27
Reduced
31
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royal Caribbean
RCL
|
+$2.8M |
| 2 |
AVYA
Avaya Holdings Corp. Common Stock
AVYA
|
+$2.38M |
| 3 |
Applied Optoelectronics
AAOI
|
+$1.6M |
| 4 |
QUOT
Quotient Technology Inc
QUOT
|
+$1.11M |
| 5 |
Ideal Power
IPWR
|
+$1.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coherent
COHR
|
+$2.41M |
| 2 |
SNCR
Synchronoss Technologies
SNCR
|
+$1.66M |
| 3 |
Digital Turbine
APPS
|
+$1.54M |
| 4 |
FLXN
Flexion Therapeutics, Inc.
FLXN
|
+$1.34M |
| 5 |
Clearfield
CLFD
|
+$1.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.03% |
| 2 | Healthcare | 9.92% |
| 3 | Consumer Discretionary | 7.96% |
| 4 | Real Estate | 3.12% |
| 5 | Consumer Staples | 2.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AERI
26
DELISTED
Aerie Pharmaceuticals
AERI
| $907K | 0.74% |
+77,038
| New | +$938K |
|
27
PUT
iShares S&P 100 ETF
OEF
$20.1B
| $816K | 0.67% |
110,100
+33,600
| +44% | +$5.17M |
|
28
Vanda Pharmaceuticals
VNDA
$307M
| $799K | 0.66% |
+82,789
| New | +$885K |
|
|
CPRX
29
DELISTED
Catalyst Pharmaceutical
CPRX
| $798K | 0.65% |
268,682
+55,732
| +26% | +$218K |
|
30
Vuzix
VUZI
$194M
| $759K | 0.62% |
166,495
-204,122
| -55% | -$798K |
|
|
BCOV
31
DELISTED
Brightcove, Inc.
BCOV
| $733K | 0.6% |
71,542
+38,673
| +118% | +$386K |
|
|
ACER
32
DELISTED
Acer Therapeutics Inc
ACER
| $722K | 0.59% |
250,518
+91,731
| +58% | +$296K |
|
33
TechTarget
TTGT
$325M
| $721K | 0.59% |
16,407
-5,216
| -24% | -$197K |
|
34
Digi International
DGII
$2.63B
| $701K | 0.58% |
+44,870
| New | +$588K |
|
|
SHSP
35
DELISTED
SharpSpring, Inc.
SHSP
| $694K | 0.57% |
+62,282
| New | +$596K |
|
36
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
| $640K | 0.53% |
6,072
-756
| -11% | -$79.6K |
|
37
Monster Beverage
MNST
$94.3B
| $621K | 0.51% |
+15,498
| New | +$612K |
|
|
ALIM
38
DELISTED
Alimera Sciences
ALIM
| $619K | 0.51% |
127,333
| – | – |
|
|
DSPG
39
DELISTED
DSP Group Inc
DSPG
| $614K | 0.5% |
46,600
+7,992
| +21% | +$118K |
|
|
FARO
40
DELISTED
Faro Technologies
FARO
| $609K | 0.5% |
9,987
+1,660
| +20% | +$95.1K |
|
|
ALNA
41
DELISTED
Allena Pharmaceuticals
ALNA
| $605K | 0.5% |
408,840
+153,840
| +60% | +$216K |
|
|
EMKR
42
DELISTED
Emcore Corp
EMKR
| $578K | 0.47% |
17,759
-769
| -4% | -$25.4K |
|
43
Annovis Bio
ANVS
$74.4M
| $575K | 0.47% |
119,538
-20,079
| -14% | -$107K |
|
44
State Street SPDR S&P Biotech ETF
XBI
$9.95B
| $571K | 0.47% |
5,121
+206
| +4% | +$23.1K |
|
45
SELLAS Life Sciences
SLS
$1.97B
| $567K | 0.47% |
+214,093
| New | +$587K |
|
|
CMRX
46
DELISTED
Chimerix, Inc.
CMRX
| $566K | 0.46% |
227,273
-106,412
| -32% | -$315K |
|
47
DHI Group
DHX
$182M
| $562K | 0.46% |
248,675
+23,537
| +10% | +$58.4K |
|
|
48
Digital Turbine
APPS
$975M
| $558K | 0.46% |
17,034
-71,363
| -81% | -$1.54M |
|
49
Gyre Therapeutics
GYRE
$641M
| $550K | 0.45% |
17,064
| – | – |
|
|
LUNA
50
DELISTED
Luna Innovations Incorporated
LUNA
| $528K | 0.43% |
+88,360
| New | +$523K |
|
Similar funds
VL
SP
OGC
PE
RL
AIIC
LGM
SCA
Worth Venture Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Worth Venture Partners held 148 positions worth $122M, down 40% from $204M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Worth Venture Partners withdrew a net $42.7M in Q3 2020, closing 34 positions and reducing 31 holdings. Its most notable exit was Coherent, an estimated $2.41M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 11% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Worth Venture Partners opened a new position in Royal Caribbean worth $3.08M.
- Worth Venture Partners's largest Q3 2020 buy was Royal Caribbean: 47,526 shares worth $3.08M.
- Worth Venture Partners added most to Ideal Power in Q3 2020, an estimated $1.01M increase.
- Worth Venture Partners's biggest Q3 2020 reduction was Digital Turbine, cutting an estimated $1.54M.
- Worth Venture Partners fully exited Coherent in Q3 2020, selling an estimated $2.41M.
- Worth Venture Partners's ten largest holdings make up 47% of its $122M portfolio in Q3 2020.
- Worth Venture Partners opened 36 new positions and closed 34 in Q3 2020.
- Worth Venture Partners's portfolio value fell 40% quarter-over-quarter to $122M.
Based on Worth Venture Partners's 13F filing for Q3 2020, filed 16 Nov 2020.